Draganfly Inc
F:3U8
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
D
|
Draganfly Inc
F:3U8
|
CA |
|
C
|
Cooper-Standard Holdings Inc
SWB:C31
|
US |
|
H
|
Hikari Tsushin Inc
XBER:HIK
|
JP |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
Sanlam Ltd
OTC:SLMAF
|
ZA |
|
L
|
Longfor Group Holdings Ltd
XBER:RLF
|
CN |
|
Intellia Therapeutics Inc
LSE:0JBU
|
US |
|
Commerzbank AG
XETRA:CBK
|
DE |
|
I
|
IDEX Corp
SWB:ID7
|
US |
|
D
|
Denso Corp
DUS:DNO
|
JP |
|
E
|
Expedia Group Inc
SWB:E3X1
|
US |
|
Five Below Inc
LSE:0IPD
|
US |
|
G
|
General Electric Co
XBER:GCP
|
US |
|
Glencore PLC
LSE:0IVW
|
CH |
|
Bayer AG
MIL:1BAYN
|
DE |
|
Forvia SE
PAR:FRVIA
|
FR |
|
S
|
Stockland Corporation Ltd
OTC:STKAF
|
AU |
|
Novavax Inc
LSE:0A3S
|
US |
|
Wal Mart de Mexico SAB de CV
BMV:WALMEX
|
MX |
|
D
|
Darling Ingredients Inc
SWB:43D
|
US |
|
C
|
Cameco Corp
XBER:CJ6
|
CA |
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
US |
|
MINISO Group Holding Ltd
NYSE:MNSO
|
CN |
|
C
|
Conagra Brands Inc
LSE:0I2P
|
US |
Reverse DCF
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|